Polymyositis: all 73 studies

Page 1 of 1. Open to participants first (19), then studies with results posted, then the rest; newest registration first within each.

• FT839 in Autoimmune DiseasesRecruitingNCT07800871Phase 1/2
• BCMA-CD19 cCAR-T for the Treatment of Refractory Inflammatory MyopathyRecruitingNCT07715136Phase 1
• MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)RecruitingNCT07374107
• Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder ArthroplastyRecruitingNCT07138898Phase 2
• Phase 2 Trial to Evaluate the Efficacy, Safety of Allogeneic Mitochondria (PN-101) in Patients With Refractory Polymyositis or DermatomyositisNot yet recruitingNCT07122648Phase 2
• A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune DiseasesRecruitingNCT07115745Phase 1
• A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.RecruitingNCT06916806Phase 1
• A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory MyopathiesRecruitingNCT06698796Phase 3
• Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune DiseasesRecruitingNCT06685042Phase 1/2
• A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)RecruitingNCT06455449Phase 3
• CAR-T Cells in Systemic B Cell Mediated Autoimmune DiseaseRecruitingNCT06347718Phase 1/2
• A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory MyopathyEnrolling by invitationNCT05979441Phase 3
• A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]RecruitingNCT05895786Phase 3
• Study Evaluating Efficacy and Safety of Froniglutide (PF1801) in Patients With Idiopathic Inflammatory MyopathyRecruitingNCT05833711Phase 2
• Natural History of Inflammatory Muscle DiseasesRecruitingNCT05738824
• Rheumatology Patient Registry and BiorepositoryRecruitingNCT04402086
• Optimizing Treatment on Idiopathic Inflammatory MyopathiesRecruitingNCT03092180
• Environmental Risk Factors for the Anti-synthetase SyndromeRecruitingNCT01276470
• Adult and Juvenile MyositisRecruitingNCT00017914
• A Phase 2 Proof of Concept Study to Evaluate the Efficacy and Safety of Daxdilimab in Participants With Dermatomyositis (DM) or Anti-synthetase Inflammatory Myositis (ASIM)CompletedNCT05669014Phase 2Results posted
• Study of M5049 in DM and PM Participants (NEPTUNIA)TerminatedNCT05650567Phase 2Results posted
• Open-label Extension to the Phase 2 Crossover Study (PRESIDIO) Evaluating KZR-616 in Patients With PM and DM.CompletedNCT04628936Phase 2Results posted
• A Phase 2 Study of KZR-616 to Evaluate Safety and Efficacy in Patients With Active Polymyositis or DermatomyositisCompletedNCT04033926Phase 2Results posted
• A Study of Ustekinumab in Participants With Active Polymyositis and Dermatomyositis Who Have Not Adequately Responded to One or More Standard-of-care TreatmentsTerminatedNCT03981744Phase 3Results posted
• Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory MyopathyCompletedNCT02971683Phase 3Results posted
• Belimumab in Idiopathic Inflammatory MyositisCompletedNCT02347891Phase 2/3Results posted
• Tocilizumab in the Treatment of Refractory Polymyositis and DermatomyositisCompletedNCT02043548Phase 2Results posted
• Acthar in Treatment of Refractory Dermatomyositis and PolymyositisCompletedNCT01906372Phase 2Results posted
• Efficacy and Tolerability of BAF312 in Patients With PolymyositisTerminatedNCT01801917Phase 2Results posted
• A Clinical Trial for CTD-ILD TreatmentTerminatedNCT01424033Phase 2/3Results posted
• Efficacy and Tolerability of BAF312 in Patients With Polymyositis and DermatomyositisTerminatedNCT01148810Phase 2Results posted
• Combined Treatment of Methotrexate + Glucocorticoids Versus Glucocorticoids Alone in Patients With PM and DMCompletedNCT00651040Phase 3Results posted
• Investigation in Myositis-associated Pneumonitis of Prednisolone And Concomitant TacrolimusCompletedNCT00504348Phase 2/3Results posted
• Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)CompletedNCT00106184Phase 2Results posted
• A Study of CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune DiseasesActive, not recruitingNCT06255028Phase 1
• Add-on Intravenous Immunoglobulins in Early MyositisActive, not recruitingNCT05832034Phase 2/3
• Plexin D1 as a Potential Biomarker inPM/DMStatus unknownNCT05637931
• A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.CompletedNCT05523167Phase 2/3
• Muscle Function and Effects of Repetitive Task Training in Patients With Inflammatory MyopatiesCompletedNCT05027152Not applicable
• Allogeneic Mitochondria (PN-101) Transplantation for Refractory Polymyositis or DermatomyositisCompletedNCT04976140Phase 1/2
• Phase 1 Study of ULSC in Patients With Polymyositis (PM) and Dermatomyositis (DM)CompletedNCT04723303Early Phase 1
• High-intensity Strength Training in MyositisCompletedNCT04486261Not applicable
• Spontaneous Coronary Artery Dissection (SCAD) and AutoimmunityCompletedNCT03941184
• PatientSpot Formerly Known as ArthritisPowerStatus unknownNCT03840928
• A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and DermatomyositisCompletedNCT03817424Phase 1
• Predictor of Clinical Response to Acthar in MyositisCompletedNCT03414086
• Effects of High-intensity Interval Training (HIIT) in Recent Onset Polymyositis and DermatomyositisStatus unknownNCT03324152Not applicable
• Epidemiological Study of Inflammatory Myopathies in a French RegionCompletedNCT02881450
• Study of the Prevalence of Polymyositis and Dermatomyositis in NormandyCompletedNCT02880527
• A Phase 1 Study of MEDI7734 in Type I Interferon-Mediated Autoimmune DiseasesCompletedNCT02780674Phase 1
• Rituximab Versus Cyclophosphamide in Connective Tissue Disease-ILDCompletedNCT01862926Phase 2/3
• Outcome in Patients With Recent Onset Polymyositis and DermatomyositisCompletedNCT01813617
• Environmental Risk Factors for Myositis in Military PersonnelCompletedNCT01734369
• Dermatomyositis and Polymyositis RegistryStatus unknownNCT01637064
• Detection of Pompe Disease in Adult Patients With Myopathies of Uncertain Origin or With Asymptomatic Hyper-CK-emiaStatus unknownNCT01482494
• Diagnostic Accuracy of Whole Body Magnetic Resonance Imaging in Inflammatory MyopathiesCompletedNCT01432613Not applicable
• Efficacy of an Individual Rehabilitation Program in Polymyositis and DermatomyositisCompletedNCT01415219Phase 2
• Abatacept Treatment in Polymyositis and DermatomyositisCompletedNCT01315938Phase 2
• Investigating Genes in Patients With Polymyositis and DermatomyositisActive, not recruitingNCT01171573
• Anakinra in MyositisCompletedNCT01165008Phase 2/3
• A Case-control Study to Assess Risk of Coronary Heart Disease in Idiopathic Inflammatory MyopathyCompletedNCT00971828
• Hand Function in Patients With Poly- or DermatomyositisCompletedNCT00866125
• Treatment With TNF Blockade, Infliximab, in Patients With MyositisCompletedNCT00443222Phase 2/3
• Studies of the Natural History and Pathogenesis of Autoimmune/Connective Tissue DiseasesCompletedNCT00341679
• Efficacy and Safety Study of GB-0998 for Treatment of Steroid-resistant Polymyositis and Dermatomyositis (PM/DM)CompletedNCT00335985Phase 3
• myoARRAY and TcLandscape Analysis for the Diagnosis of Inflammatory MyopathiesCompletedNCT00213629Not applicable
• Prevention of Glucocorticoid-Induced Osteoporosis in Rheumatic Diseases: Alendronate Versus Alfacalcidol.CompletedNCT00138983Phase 3
• Infliximab (Remicade ) to Treat Dermatomyositis and PolymyositisCompletedNCT00033891Phase 2
• Methimazole to Treat Polymyositis and DermatomyositisCompletedNCT00001421Phase 2
• Genetic and Family Studies of Inherited Muscle DiseasesCompletedNCT00001331
• Study and Treatment of Inflammatory Muscle DiseasesCompletedNCT00001265
• Intravenousimmunoglobulin (IVIg) for the Treatment of Inflammatory MyopathiesCompletedNCT00001261Phase 2
• Ultrasound Evaluation of Tongue Movements in Speech and SwallowingCompletedNCT00001167

← Polymyositis overview